尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Solaiman Shereen. Director active across 1 company, notably Myriad Genetics INC. Aggregated, 7 reports have been logged. Activity tracked since 1 March 2023. The latest transaction was disclosed on 12 March 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Solaiman Shereen is Chief People Officer at Myriad Genetics INC (XNAS). She has 7 filings in total, and the sampled recent filings run from 2023-03-02 to 2026-03-16, with Attribution transactions in that sample, and the largest amounts at 22744.56976609319, 19735.95682483268, and 6542.175498075972 EUR.